| Literature DB >> 20435192 |
Khalid Abozguia1, Ganesh Nallur-Shivu, Thanh T Phan, Ibrar Ahmed, Rajat Kalra, Rebekah A Weaver, William J McKenna, John E Sanderson, Perry Elliott, Michael P Frenneaux.
Abstract
BACKGROUND: Nonobstructive hypertrophic cardiomyopathy (nHCM) is often associated with reduced exercise capacity despite hyperdynamic systolic function as measured by left ventricular ejection fraction. We sought to examine the importance of left ventricular strain, twist, and untwist as predictors of exercise capacity in nHCM patients.Entities:
Mesh:
Year: 2010 PMID: 20435192 PMCID: PMC2877779 DOI: 10.1016/j.ahj.2010.02.002
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749
Figure 1Illustration of STE measurement of rotation and twist in a control subject. To adjust for heart rate, R-R interval was converted to 100%. Green line represents global apical rotation. whereas red line represents global basal rotation. At apical level, the LV rotates counterclockwise as viewed from apex and results in a positive value during systole, whereas the base rotates clockwise and results in a negative value, as in this representative case. Black dotted line represents LV twist that was calculated as the simultaneous net difference between apical and basal rotation. Blue dotted line represents the LV twist rate that was calculated as a differential curve of the twist curve.
The clinical characteristics and cardiopulmonary exercise test results of nHCM patients and controls
| Parameter | nHCM | Controls | |
|---|---|---|---|
| Age (y) | 52 ± 11 | 51 ± 16 | .74 |
| n (female) | 56 (16) | 43 (12) | .64 |
| Heart rate (beat/min) | 69 ± 13 | 80 ± 16 | .0002 |
| Systolic BP (mm Hg) | 126 ± 19 | 125 ± 20 | .78 |
| Diastolic BP (mm Hg) | 78 ± 11 | 78 ± 11 | .80 |
| Peak V | 23.28 ± 6.31 | 37.70 ± 7.99 | <.0001 |
| Drug therapy, n (%) | |||
| Diuretic | 10 (18) | 0 | – |
| ACE inhibitor | 6 (11) | 0 | – |
| ARB | 1 (2) | 0 | – |
| β-Blocker | 17 (31) | 0 | – |
| Calcium-channel blocker | 26 (47) | 0 | – |
| Aspirin | 13 (24) | 0 | – |
| Warfarin | 5 (9) | 0 | – |
| Nitrate | 2 (4) | 0 | – |
| Statin | 15 (27) | 0 | – |
BP, Blood pressure; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers.
Indicates statistical significance.
Standard, Doppler, and PW-TDI echocardiographic characteristics of nHCM versus controls
| Parameter | nHCM | Controls | |
|---|---|---|---|
| EF biplane (%) | 62.76 ± 9.05 | 62.48 ± 5.82 | .86 |
| Biplane LA volume (mL) | 72.69 ± 29.22 | 35.09 ± 9.83 | <.0001 |
| LAVI (mL/m2) | 33.92 ± 14.62 | 11.76 ± 10.17 | <.0001 |
| LV mass index (g/m2) | 181.92 ± 84.09 | 71.67 ± 23.82 | <.0001 |
| MV E (m/s) | 0.69 ± 0.16 | 0.67 ± 0.15 | .49 |
| MV A (m/s) | 0.64 ± 0.19 | 0.59 ± 0.15 | .17 |
| MV E/A | 1.18 ± 0.48 | 1.20 ± 0.38 | .83 |
| MV dec time (ms) | 231.12 ± 71.66 | 260.10 ± 68.24 | .06 |
| Antlat Sm (cm/s) | 0.06 ± 0.02 | 0.10 ± 0.03 | <.0001 |
| Antlat Em (cm/s) | 0.08 ± 0.03 | 0.11 ± 0.04 | <.0001 |
| Antlat Am (cm/s) | 0.07 ± 0.03 | 0.09 ± 0.02 | <.0001 |
| Infsep Sm (cm/s) | 0.06 ± 0.02 | 0.08 ± 0.02 | .0001 |
| Infsep Em (cm/s) | 0.05 ± 0.02 | 0.08 ± 0.03 | <.0001 |
| Infsep Am (cm/s) | 0.07 ± 0.02 | 0.09 ± 0.02 | <.0001 |
| Average Sm (cm/s) | 0.06 ± 0.02 | 0.09 ± 0.02 | <.0001 |
| Average Em (cm/s) | 0.06 ± 0.02 | 0.09 ± 0.04 | <.0001 |
| E/Emantlat | 9.70 ± 3.86 | 6.71 ± 2.35 | .0001 |
| E/Eminfsep | 17.05 ± 7.38 | 9.64 ± 3.34 | <.0001 |
| E/Emaverage | 11.81 ± 4.28 | 8.04 ± 2.92 | <.0001 |
MV E, Transmitral early diastole velocity; MV A, transmitral late diastole velocity; dec, deceleration.
Indicates statistical significance.
STE results of longitudinal, radial, and circumferential strain and strain rates in nHCM patients versus controls
| Parameter | nHCM | Controls | |
|---|---|---|---|
| Longitudinal | |||
| SL peak S (%) | −12.74 ± 4.21 | −18.38 ± 2.99 | <.0001 |
| SrL peak S (1/s) | −0.92 ± 0.25 | −1.14 ± 0.2 | <.0001 |
| SrL peak E (1/s) | 0.94 ± 0.35 | 1.33 ± 0.3 | <.0001 |
| SrL peak A (1/s) | 0.78 ± 0.28 | 1.07 ± 0.29 | <.0001 |
| Radial | |||
| SR peak S (%) | 17.52 ± 7.86 | 29.63 ± 13.26 | <.0001 |
| SrR peak S (1/s) | 1.22 ± 0.34 | 1.39 ± 0.34 | .02 |
| SrR peak E (1/s) | −1.0 ± 0.39 | −1.46 ± 0.52 | <.0001 |
| SrR peak A (1/s) | −0.77 ± 0.38 | −1.09 ± 0.61 | <.01 |
| Circumferential | |||
| SC peak S (%) | −16.50 ± 4.29 | −19.99 ± 5.53 | <.001 |
| SrC peak S (1/s) | −1.4 ± 0.35 | −1.54 ± 0.34 | .05 |
| SrC peak E (1/s) | 1.34 ± 0.42 | 1.8 ± 0.65 | <.001 |
| SrC peak A (1/s) | 0.87 ± 0.34 | 1.09 ± 0.47 | .02⁎ |
SL, Longitudinal strain; SR, radial strain, SrR, radial strain rate; SC, circumferential strain.
Indicates statistical significance.
STE measurement of LV rotation, twist, and untwist in nHCM and controls
| Parameter | nHCM | Controls | |
|---|---|---|---|
| Apical rot and rot-r | |||
| Peak rot (°) | 7.65 ± 6.90 | 9.48 ± 5.40 | .18 |
| Peak S rot-r (°/s) | 49.77 ± 49.49 | 74.56 ± 42.25 | .01 |
| Peak E rot-r (°/s) | −41.19 ± 39.14 | −72.96 ± 38.00 | <.001 |
| Peak A rot-r (°/s) | −26.24 ± 33.94 | −39.87 ± 27.01 | <.05 |
| Basal rot and rot-r | |||
| Peak rot (°) | −6.25 ± 3.73 | −5.80 ± 2.81 | .55 |
| Peak S rot-r (°/s) | −57.89 ± 28.94 | −61.24 ± 17.82 | .54 |
| Peak E rot-r (°/s) | 53.07 ± 25.96 | 48.88 ± 26.42 | .47 |
| Peak S rot-r (°/s) | 42.39 ± 24.52 | 44.67 ± 20.68 | .65 |
| Twist and untwist | |||
| Peak twist (°) | 13.37 ± 7.14 | 13.69 ± 6.55 | .83 |
| 25% Untwist (°) | 9.85 ± 5.47 | 10.27 ± 4.91 | .71 |
| Time 25% untwist (R-R%) | 11.34 ± 5.63 | 7.21 ± 8.01 | .01 |
R-R, R-R interval.
Indicates statistical significance.
Figure 2Correlation between exercise capacity (peak Vo2) and (A) LV mass index, (B) maximal wall thickness, and (C) LV volume index.
Figure 3Correlation between exercise capacity (peak Vo2) and (A) SrL peak S, (B) SrL peak E, (C) SrL peak A, and (D) 25% untwist.